ARCHIVES

Patient Accrual Up More Than 20% This Year Despite Lack Of Significant New Money For Group

This article is from The Cancer Letter archive.

Vol. 14 No. 45 | November 18, 1988

Download PDF Visit The Full Archive

Related Articles

ACCC Seeking Line Item, $21 Million for CCPs; Results Of Evaluation Released

June 5, 1987

NCCS Networker Volume 5 Issue 3, Summer 1991

June 13, 1991

SWOG, NCI Canada halt two large trials of Iressa for non-small cell lung cancer.

April 22, 2005

OD Contract Concepts Okayed

October 17, 1986

Contract Awards: Texas Group Receives $472,000 To Monitor Asbestos Workers

August 23, 1974

FDA Approves Rituxan For CLL

February 19, 2010